AMERIPRISE FINANCIAL INC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2014. The put-call ratio across all filers is 2.83 and the average weighting 1.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2014$1,000
-50.0%
400
-20.0%
0.00%
Q2 2014$2,0000.0%500
+25.0%
0.00%
Q1 2014$2,0000.0%4000.0%0.00%
Q4 2013$2,000
-89.5%
400
-86.7%
0.00%
Q3 2013$19,000
+26.7%
3,0180.0%0.00%
Q2 2013$15,0003,0180.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q2 2014
NameSharesValueWeighting ↓
CAXTON CORP 28,639,349$123,436,00094.21%
Verity Asset Management, Inc. 103,021$456,0000.47%
NBW CAPITAL LLC 242,153$1,044,0000.27%
Old West Investment Management, LLC 69,997$301,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 196,639$848,0000.12%
SOPHROSYNE CAPITAL LLC 25,700$111,0000.10%
Cutler Capital Management, LLC 45,000$194,0000.08%
Rotella Capital Management, Inc. 11,700$50,0000.06%
STONERIDGE INVESTMENT PARTNERS LLC 66,397$286,0000.06%
Roundview Capital LLC 21,100$91,0000.04%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders